Nuclear Medicine Center, Biotech Laboratory to be Set Up in Skolkovo Medical Cluster

| By | Russian Pharma, Skolkovo
0
100

Skolkovo Foundation concluded six agreements to facilitate medical, educational and research projects in healthcare at the St. Petersburg international economic forum.

A versatile full-cycle biotechnological laboratory, a technological valley for developing artificial intelligence in healthcare, centers of nuclear medicine and drug cancer therapy, and a digital educational platform will be created under these agreements, Moscow’s Vice Mayor for Urban Policy and Construction Marat Khusnullin told the media.

By signing agreements aimed at promoting these projects, the medical cluster will continue drawing new foreign clinics to its territory and vigorously broaden its educational and research activities, he said.

The medical cluster is drawing both foreign and Russian residents, Mikhail Yugai, general director of the International Medical Cluster Foundation, said.

The transfer of international practices and technologies alone will not be sufficient to allow the Russian system of healthcare to accomplish a breakthrough we count on. Therefore, we have been looking for and finding strong Russian partners ready to team up with us and further develop healthcare in this country along all strategic lines,

he said.

The project to form the Skolkovo International Medical Cluster already involves four international partners: the Israeli clinic Hadassah, the South Korean hospital Bundang, the Spanish clinic Roman Fernandez and the French company ORPEA Group which will build a high-technology medical rehabilitation center, Clinea.

Khusnullin earlier said that the International Medical Cluster Foundation continues efforts to draw investors. Twenty-five foreign clinics and five foreign investors have expressed tentative agreement to join the Skolkovo medical cluster project, he said.

The Moscow authorities in May made the decision to expand the medical cluster’s area from 425,000 to 858,000 square meters.

SOURCE: interfax.ru
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.